A 52-year-old woman with a medical history of hepatitis B, hyperlipidemia, hypertension, anemia, and depression presented to the internal medicine clinic for a routine visit. Laboratory tests 3 months previously had revealed an impaired fasting glucose concentration of 5.9 mmol/L (106 mg/dL) [reference interval, 3.9 -5.6 mmol/L (70-100 mg/dL)]. Therefore, a hemoglobin (Hb) 2 A 1c analysis was performed. The initial Hb A 1c evaluation by cation-exchange HPLC (CE-HPLC) (Hb A 1c Program on the VARIANT IITURBOLink System; Bio-Rad Laboratories) showed an Hb A 1c value of 115.8% (reference interval, 4.0%-6.0%) ( Fig. 1) . In an effort to determine if the unusual Hb A 1c result was due to potential hemoglobinopathies, we performed an Hb variant analysis with the Bio-Rad VARIANT CE-HPLC β-Thalassemia Short Program. The analysis revealed the absence of Hb A and the presence of sickle cell Hb (Hb S) (37.4%), along with normal Hb A 2 (3.2%) and Hb F (<1.0%) (Fig. 2) . Also evident was another large peak (53.0%) that eluted earlier than Hb A, which we called P2. This study suggested the presence of an Hb variant with a chromatographic retention time virtually identical to that of Hb A 1c , in addition to Hb S (Figs. 1 and 2) . A subsequent Hb electrophoretic analysis at pH 6.0 (QuickGel Acid; Helena Laboratories) identified Hb S and another abnormal band with a mobility similar to Hb F (not shown).
PATIENT FOLLOW-UP
To identify the Hb variants, we investigated DNA sequences corresponding to the patient's_β-globin genes. This analysis identified a substitution at codon 6 [GAG to GTG (Glu to Val)] on one allele, corresponding to Hb S, and a substitution at codon 1 [GTG to GCG (Val to Ala)] on the other allele, corresponding to Hb Raleigh. The presence of these hemoglobinopathies suggested that the spuriousHbA 1c result obtained with the CE-HPLC method was due to the elution of Hb Raleigh, which has a retention time similar to that of Hb A 1c .We evaluated the Hb A 1c result with a turbidimetric inhibition immunoassay (Dimension ® Clinical Chemistry System; Siemens) and obtained an Hb A 1c value of 4.1%, which was not consistent with the impaired fasting glucose concentration of 5.9 mmol/L (106 mg/dL).
